What is the maximum safe positive end‑expiratory pressure (PEEP) for an adult with end‑stage acute respiratory distress syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum PEEP for End-Stage ARDS

For adults with end-stage (severe) ARDS, there is no absolute maximum PEEP ceiling, but higher PEEP strategies (typically 13-15 cm H₂O) are conditionally recommended over lower PEEP (8-9 cm H₂O), with the critical constraint that plateau pressure must remain ≤30 cm H₂O 1, 2.

Evidence-Based PEEP Strategy

The most recent 2024 ATS guideline provides a conditional recommendation for higher PEEP without lung recruitment maneuvers in moderate to severe ARDS 1. This builds on the 2017 ATS/ESICM/SCCM guideline that established higher PEEP strategies reduce mortality specifically in moderate-to-severe ARDS (PaO₂/FiO₂ <200), with an adjusted relative risk of 0.90 2.

Practical PEEP Ranges

  • Higher PEEP strategy: Mean 13-15 cm H₂O (range typically 12-18 cm H₂O) 2, 3
  • Lower PEEP strategy: Mean 8-9 cm H₂O 2, 3
  • Historical high-level PEEP: >15 cm H₂O has been used successfully in severe ARDS with 70% survival when titrated to reduce shunt fraction to ≤0.20 4

Critical Safety Constraints

The true "maximum" PEEP is determined by plateau pressure, not an arbitrary PEEP number. You must maintain:

  • Plateau pressure ≤30 cm H₂O (strong recommendation) 2
  • Tidal volume 4-8 mL/kg predicted body weight 2

This means the actual maximum tolerable PEEP varies by patient based on respiratory system compliance. In patients with very poor compliance, even moderate PEEP levels may exceed safe plateau pressures.

Physiologic Considerations for End-Stage ARDS

Lung Recruitability Matters

Recent evidence demonstrates that PEEP effects depend critically on lung recruitability 5, 6:

  • High recruiters (recruitment-to-inflation ratio ≥0.5): Higher PEEP improves oxygenation without increasing pulmonary vascular resistance 5
  • Low recruiters (R/I ratio <0.5): Higher PEEP increases pulmonary vascular resistance and right ventricular strain without proportional benefit 5

This explains why blanket high PEEP strategies show only conditional benefit—individual lung mechanics determine optimal PEEP.

Hemodynamic Monitoring

Higher PEEP can compromise cardiac output through:

  • Increased right ventricular afterload (especially in low recruiters) 7, 5
  • Decreased venous return in preload-responsive patients 5

Monitor for signs of right ventricular dysfunction and be prepared to support hemodynamics with fluids and vasopressors rather than abandoning higher PEEP if oxygenation benefits are substantial.

What NOT to Do

Avoid prolonged recruitment maneuvers with higher PEEP (strong recommendation against) 1. A 2022 network meta-analysis showed higher PEEP with prolonged recruitment maneuvers had 99% posterior probability of increased mortality compared to higher PEEP without recruitment maneuvers (RR 1.37) 6.

Special Circumstances in End-Stage ARDS

During Prone Positioning

When using prone positioning (strongly recommended for severe ARDS >12 hours/day) 2, respiratory mechanics change significantly and PEEP strategy may need reassessment 8.

With VV-ECMO

If the patient progresses to VV-ECMO for refractory hypoxemia, transition to "ultraprotective" ventilation with lower PEEP as part of lung rest strategy, since recruitment for oxygenation becomes less critical 8.

Practical Algorithm

  1. Start with higher PEEP strategy (12-15 cm H₂O) in severe ARDS
  2. Ensure plateau pressure ≤30 cm H₂O at all times
  3. Assess response: Improved oxygenation without hemodynamic compromise suggests adequate recruitment
  4. Monitor for complications: Rising plateau pressure, hemodynamic instability, or barotrauma
  5. Consider personalized titration using esophageal pressure or EIT if available 9, though this requires specialized expertise

The evidence supports that mortality benefit from higher PEEP exists specifically in moderate-to-severe ARDS, with moderate certainty 1, 2, 6. The "maximum" is therefore a physiologic limit (plateau pressure ≤30 cm H₂O), not a fixed PEEP number.

References

Related Questions

What is the target positive end-expiratory pressure (PEEP) for intubated patients?
What is the incremental positive end‑expiratory pressure (PEEP) titration strategy for acute respiratory distress syndrome (ARDS) and what is the optimal lung recruitment strategy?
What is the difference between Positive End-Expiratory Pressure (PEEP) and Peak Inspiratory Pressure (PIP) in patients requiring mechanical ventilation, particularly in those with underlying lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) or Acute Respiratory Distress Syndrome (ARDS)?
How do I use electrical impedance tomography (EIT) at the bedside to assess regional lung ventilation and guide ventilator settings in mechanically ventilated patients with acute respiratory distress syndrome (ARDS)?
Should we increase the positive end‑expiratory pressure (PEEP) in an adult mechanically ventilated patient who has developed atelectasis with decreasing oxygen saturation?
Is chloronychia (green nail infection caused by Pseudomonas aeruginosa) contagious?
What are the possible causes of elevated hemoglobin, hematocrit, and red‑cell distribution width, and how should they be evaluated?
Is there an association between Ozempic (semaglutide) use and an increased risk of brain tumors?
Should Stemetil (prochlorperazine) be taken before or after meals?
Is bremelanotide (brand name Vyleesi) the same compound as PT‑141?
What is the recommended treatment for chronic syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.